Ahmed Shahid, Leis Anne, Chandra-Kanthan Selliah, Fields Anthony, Zaidi Adnan, Abbas Tahir, Le Duc, Reeder Bruce, Pahwa Punam
Saskatchewan Cancer Agency, Saskatoon, SK, Canada.
Department of Oncology, University of Saskatchewan, Saskatoon, SK, Canada.
Ann Surg Oncol. 2016 Jul;23(7):2287-94. doi: 10.1245/s10434-016-5200-9. Epub 2016 Mar 25.
Although lymph nodes status and the ratio of metastatic to examined lymph node (LNR) are important prognostic factors in early-stage colorectal cancer (CRC), their significance in patients with metastatic disease remains unknown. The study aims to determine prognostic importance of nodal status and LNR in patients with stage IV CRC.
A cohort of 1109 eligible patients who were diagnosed with synchronous metastatic CRC in Saskatchewan during 1992-2010 and underwent primary tumor resection was evaluated. We conducted the Cox proportional multivariate analyses to determine the prognostic significance of nodal status and LNR.
Median age was 70 years (22-98) and M:F was 1.2:1. Rectal cancer was found in 26 % of patients; 96 % had T3/T4 tumor, and 82 % had node positive disease. The median LNR was 0.36 (0-1.0). Fifty-four percent received chemotherapy. Median overall survival of patients who had LNR of <0.36 and received chemotherapy was 29.7 months (95 % CI 26.6-32.9) compared with 15.6 months (95 % CI 13.6-17.6) with LNR of ≥0.36 (P < .001). On multivariate analyses, no chemotherapy (HR 2.36 [2.0-2.79]), not having metastasectomy (HR 1.94 [1.63-2.32]), LNR ≥0.36 (HR 1.59 [1.38-1.84]). nodal status (HR 1.34 [1.14-1.59]), and T status (HR 1.23 [1.07-1.40]) were correlated with survival. Test for interaction was positive for LNR and high-grade cancer (HR 1.51 [1.10-2.10]).
Our results suggest that nodal status and LNR are important prognostic factors independent of chemotherapy and metastasectomy in stage IV CRC patients.
尽管淋巴结状态以及转移淋巴结与检查淋巴结的比例(LNR)是早期结直肠癌(CRC)重要的预后因素,但其在转移性疾病患者中的意义仍不明确。本研究旨在确定IV期CRC患者中淋巴结状态和LNR的预后重要性。
对1992年至2010年期间在萨斯喀彻温省被诊断为同步转移性CRC并接受原发肿瘤切除的1109例符合条件的患者进行队列研究。我们进行了Cox比例多因素分析以确定淋巴结状态和LNR的预后意义。
中位年龄为70岁(22 - 98岁),男女比例为1.2:1。26%的患者为直肠癌;96%有T3/T4肿瘤,82%有淋巴结阳性疾病。中位LNR为0.36(0 - 1.0)。54%的患者接受了化疗。LNR<0.36且接受化疗的患者中位总生存期为29.7个月(95%CI 26.6 - 32.9),而LNR≥0.36的患者为15.6个月(95%CI 13.6 - 17.6)(P<.001)。多因素分析显示,未接受化疗(HR 2.36 [2.0 - 2.79])、未进行转移灶切除术(HR 1.94 [1.63 - 2.32])、LNR≥0.36(HR 1.59 [1.38 - 1.84])、淋巴结状态(HR 1.34 [1.14 - 1.59])和T分期(HR 1.23 [1.07 - 1.40])与生存相关。LNR与高级别癌症的交互检验为阳性(HR 1.51 [1.10 - 2.10])。
我们的结果表明,在IV期CRC患者中,淋巴结状态和LNR是独立于化疗和转移灶切除术的重要预后因素。